中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 41 Issue 9
Sep.  2025
Turn off MathJax
Article Contents

Application of the “two-hit” hypothesis in animal models of alcoholic liver disease

DOI: 10.12449/JCH250932
Research funding:

National Natural Science Foundation of China (82000557)

More Information
  • Corresponding author: XIE Yandi, xieyandee@163.com (ORCID: 0000-0001-5002-341X)
  • Received Date: 2025-01-04
  • Accepted Date: 2025-03-21
  • Published Date: 2025-09-25
  • Alcoholic liver disease (ALD) poses a serious threat to the health of drinkers worldwide, and establishing appropriate animal models of ALD is an important foundation for conducting disease-related research. Due to the physiological and pathophysiological differences between rodents and humans, alcohol feeding alone is difficult to induce a model that closely matches the disease manifestations in humans, and therefore, the “two-hit” hypothesis ( combining alcohol with another liver injury factor to induce the expected state of liver injury) has been widely used. This article classifies the more commonly used and effective “two-hit” regimens into three major categories of special diets, chemical substances, and genetic engineering, which are divided into high-fat diet, high-iron diet, carbon tetrachloride, lipopolysaccharide, and genetic engineering for further analysis. Although these five “two-hit” models have their own advantages and disadvantages, they can nearly cover the disease spectrum of ALD. In the future, the development of ALD animal models can focus on narrowing the pathophysiological differences in alcohol-induced liver injury between animals and humans and simulating more complex drinking patterns in humans.

     

  • loading
  • [1]
    BRANDON-WARNER E, SCHRUM LW, SCHMIDT CM, et al. Rodent models of alcoholic liver disease: of mice and men[J]. Alcohol, 2012, 46( 8): 715- 725. DOI: 10.1016/j.alcohol.2012.08.004.
    [2]
    TSUKAMOTO H, MACHIDA K, DYNNYK A, et al.“Second hit” models of alcoholic liver disease[J]. Semin Liver Dis, 2009, 29( 2): 178- 187. DOI: 10.1055/s-0029-1214373.
    [3]
    GÄBELE E, DOSTERT K, DORN C, et al. A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis[J]. Alcohol Clin Exp Res, 2011, 35( 7): 1361- 1367. DOI: 10.1111/j.1530-0277.2011.01472.x.
    [4]
    ZHANG XQ, XU CF, YU CH, et al. Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease[J]. World J Gastroenterol, 2014, 20( 7): 1768- 1776. DOI: 10.3748/wjg.v20.i7.1768.
    [5]
    HWANG S, REN TY, GAO B. Obesity and binge alcohol intake are deadly combination to induce steatohepatitis: A model of high-fat diet and binge ethanol intake[J]. Clin Mol Hepatol, 2020, 26( 4): 586- 594. DOI: 10.3350/cmh.2020.0100.
    [6]
    BISHEHSARI F, MAGNO E, SWANSON G, et al. Alcohol and gut-derived inflammation[J]. Alcohol Res, 2017, 38( 2): 163- 171.
    [7]
    KIRPICH IA, MILLER ME, CAVE MC, et al. Alcoholic liver disease: Update on the role of dietary fat[J]. Biomolecules, 2016, 6( 1): 1. DOI: 10.3390/biom6010001.
    [8]
    CHEN P, TORRALBA M, TAN J, et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice[J]. Gastroenterology, 2015, 148( 1): 203- 214.e16. DOI: 10.1053/j.gastro.2014.09.014.
    [9]
    CHEN YL, PENG HC, WANG XD, et al. Dietary saturated fatty acids reduce hepatic lipid accumulation but induce fibrotic change in alcohol-fed rats[J]. Hepatobiliary Surg Nutr, 2015, 4( 3): 172- 183. DOI: 10.3978/j.issn.2304-3881.2015.01.04.
    [10]
    KIRPICH IA, PETROSINO J, AJAMI N, et al. Saturated and unsaturated dietary fats differentially modulate ethanol-induced changes in gut microbiome and metabolome in a mouse model of alcoholic liver disease[J]. Am J Pathol, 2016, 186( 4): 765- 776. DOI: 10.1016/j.ajpath.2015.11.017.
    [11]
    SENGUPTA M, ABUIRQEBA S, KAMERIC A, et al. A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis[J]. PLoS One, 2021, 16( 3): e0249316. DOI: 10.1371/journal.pone.0249316.
    [12]
    SCHONFELD M, O’NEIL M, VILLAR MT, et al. A Western diet with alcohol in drinking water recapitulates features of alcohol-associated liver disease in mice[J]. Alcohol Clin Exp Res, 2021, 45( 10): 1980- 1993. DOI: 10.1111/acer.14700.
    [13]
    PARKER R, KIM SJ, GAO B. Alcohol, adipose tissue and liver disease: Mechanistic links and clinical considerations[J]. Nat Rev Gastroenterol Hepatol, 2018, 15( 1): 50- 59. DOI: 10.1038/nrgastro.2017.116.
    [14]
    GAO B, XU MJ, BERTOLA A, et al. Animal models of alcoholic liver disease: Pathogenesis and clinical relevance[J]. Gene Expr, 2017, 17( 3): 173- 186. DOI: 10.3727/105221617X695519.
    [15]
    HARRISON-FINDIK DD, KLEIN E, CRIST C, et al. Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol[J]. Hepatology, 2007, 46( 6): 1979- 1985. DOI: 10.1002/hep.21895.
    [16]
    OHTAKE T, SAITO H, HOSOKI Y, et al. Hepcidin is down-regulated in alcohol loading[J]. Alcoholism Clin Exp Res, 2007, 31( S1): S2- S8. DOI: 10.1111/j.1530-0277.2006.00279.x
    [17]
    BRIDLEK, CHEUNGTK, MURPHYT, et al. Hepcidin is down-regulated in alcoholic liver injury: Implications for the pathogenesis of alcoholic liver disease[J]. Alcohol Clin Exp Res, 2006, 30( 1): 106- 112. DOI: 10.1111/j.1530-0277.2006.00002.x.
    [18]
    SIKORSKA K, STALKE P, ROMANOWSKI T, et al. Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C[J]. Hepatobiliary Pancreat Dis Int, 2013, 12( 4): 377- 384. DOI: 10.1016/s1499-3872(13)60059-4.
    [19]
    OLYNYK J, HALL P, REED W, et al. A long-term study of the interaction between iron and alcohol in an animal model of iron overload[J]. J Hepatol, 1995, 22( 6): 671- 676. DOI: 10.1016/0168-8278(95)80222-3.
    [20]
    TSUKAMOTO H, HORNE W, KAMIMURA S, et al. Experimental liver cirrhosis induced by alcohol and iron[J]. J Clin Invest, 1995, 96( 1): 620- 630. DOI: 10.1172/JCI118077.
    [21]
    NISHIMAKI-MOGAMI T, SUZUKI K, TAKAHASHI A. The role of phosphatidylethanolamine methylation in the secretion of very low density lipoproteins by cultured rat hepatocytes: Rapid inhibition of phosphatidylethanolamine methylation by bezafibrate increases the density of apolipoprotein B48-containing lipoproteins[J]. Biochim Biophys Acta, 1996, 1304( 1): 21- 31. DOI: 10.1016/s0005-2760(96)00100-2.
    [22]
    GRUEBELE A, ZAWASKI K, KAPLAN D, et al. Cytochrome P4502E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: Effects on signal transduction as demonstrated by altered immediate-early(c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-kappa B transcription factor levels[J]. Drug Metab Dispos, 1996, 24( 1): 15- 22.
    [23]
    SCHOLTEN D, TREBICKA J, LIEDTKE C, et al. The carbon tetrachloride model in mice[J]. Lab Anim, 2015, 49( S1): 4- 11. DOI: 10.1177/002367-7215571192.
    [24]
    DOMENICALI M, CARACENI P, GIANNONE F, et al. A novel model of CCl4-induced cirrhosis with ascites in the mouse[J]. J Hepatol, 2009, 51( 6): 991- 999. DOI: 10.1016/j.jhep.2009.09.008.
    [25]
    LIEDTKE C, LUEDDE T, SAUERBRUCH T, et al. Experimental liver fibrosis research: Update on animal models, legal issues and translational aspects[J]. Fibrogenesis Tissue Repair, 2013, 6( 1): 19. DOI: 10.1186/1755-1536-6-19.
    [26]
    FACCIOLI LAP, DIAS ML, PARANHOS BA, et al. Liver cirrhosis: An overview of experimental models in rodents[J]. Life Sci, 2022, 301: 120615. DOI: 10.1016/j.lfs.2022.120615.
    [27]
    BOSMA A, BROUWER A, SEIFERT WF, et al. Synergism between ethanol and carbon tetrachloride in the generation of liver fibrosis[J]. J Pathol, 1988, 156( 1): 15- 21. DOI: 10.1002/path.1711560106.
    [28]
    WEBER LWD, BOLL M, STAMPFL A. Hepatotoxicity and mechanism of action of haloalkanes: Carbon tetrachloride as a toxicological model[J]. Crit Rev Toxicol, 2003, 33( 2): 105- 136. DOI: 10.1080/713611034.
    [29]
    COHEN JI, NAGY LE. Pathogenesis of alcoholic liver disease: Interactions between parenchymal and non-parenchymal cells[J]. J Dig Dis, 2011, 12( 1): 3- 9. DOI: 10.1111/j.1751-2980.2010.00468.x.
    [30]
    GUHA M, MACKMAN N. LPS induction of gene expression in human monocytes[J]. Cell Signal, 2001, 13( 2): 85- 94. DOI: 10.1016/s0898-6568(00)00149-2.
    [31]
    GAO B, BATALLER R. Alcoholic liver disease: Pathogenesis and new therapeutic targets[J]. Gastroenterology, 2011, 141( 5): 1572- 1585. DOI: 10.1053/j.gastro.2011.09.002.
    [32]
    ZIMA T, KALOUSOVÁ M. Oxidative stress and signal transduction pathways in alcoholic liver disease[J]. Alcohol Clin Exp Res, 2005, 29( 11 Suppl): 110S- 115S. DOI: 10.1097/01.alc.0000189288.30358.4b.
    [33]
    REYES-GORDILLO K, SHAH R, ARELLANES-ROBLEDO J, et al. Akt1 and Akt2 isoforms play distinct roles in regulating the development of inflammation and fibrosis associated with alcoholic liver disease[J]. Cells, 2019, 8( 11): 1337. DOI: 10.3390/cells8111337.
    [34]
    PENNINGTON HL, HALL PM, WILCE PA, et al. Ethanol feeding enhances inflammatory cytokine expression in lipopolysaccharide-induced hepatitis[J]. J Gastroenterol Hepatol, 1997, 12( 4): 305- 313. DOI: 10.1111/j.1440-1746.1997.tb00426.x.
    [35]
    de la M HALL P, LIEBER CS, DECARLI LM, et al. Models of alcoholic liver disease in rodents: a critical evaluation[J]. Alcohol Clin Exp Res, 2001, 25(5 Suppl ISBRA): 254S- 261S. DOI: 10.1097/00000374-200105-051-00041.
    [36]
    XU JS, XU Y, LI YY, et al. Carboxylesterase 1 is regulated by hepatocyte nuclear factor 4α and protects against alcohol- and MCD diet-induced liver injury[J]. Sci Rep, 2016, 6: 24277. DOI: 10.1038/srep24277.
    [37]
    XU MJ, CAI Y, WANG H, et al. Fat-specific protein 27/CIDEC promotes development of alcoholic steatohepatitis in mice and humans[J]. Gastroenterology, 2015, 149( 4): 1030- 1041. e 6. DOI: 10.1053/j.gastro.2015.06.009.
    [38]
    LU YK, WU DF, WANG XD, et al. Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice[J]. Free Radic Biol Med, 2010, 49( 9): 1406- 1416. DOI: 10.1016/j.freeradbiomed.2010.07.026.
    [39]
    BUTURA A, NILSSON K, MORGAN K, et al. The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model[J]. J Hepatol, 2009, 50( 3): 572- 583. DOI: 10.1016/j.jhep.2008.10.020.
    [40]
    Hepatology Branch of the Chinese Medical Association. Guidelines for the prevention and treatment of metabolism-related(non-alcoholic) fatty liver disease(2024 edition)[J]. J Prac Hepatol, 2024, 27( 4): 494- 510. DOI: 10.3760/cma.j.cn501113-20240327-00163.

    中华医学会肝病学分会. 代谢相关(非酒精性)脂肪性肝病防治指南(2024年版)[J]. 实用肝脏病杂志, 2024, 27( 4): 494- 510. DOI: 10.3760/cma.j.cn501113-20240327-00163.
    [41]
    TACKE F, HORN P, WONG VW, et al. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease(MASLD)[J]. J Hepatol, 2024, 81( 3): 492- 542. DOI: 10.1016/j.jhep.2024.04.031.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(1)

    Article Metrics

    Article views (101) PDF downloads(16) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return